Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Aug 29;9:147–154. doi: 10.2147/JIR.S110873

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2016 Sahin et al. This work is published and licensed by Dove Medical Press Limited

The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

PMC Copyright notice

Effect of different treatments on NF-kB (A), I-kB (B), HSP70 (C), TRX-1 (D), SIRT1 (E), PGC-1α (F), Nrf2 (G), HO-1 (H), and GLUT4 (I) protein expression levels of muscle.

Note: Superscripts differ by alphabets represent significance at P<0.05.

Abbreviations: GLUT4; glucose transporter 4; HO-1, hemeoxygenase-1; HSP70, heat shock protein 70; I-κB, inhibitors of kappa B; NF-kB; nuclear factor kappa-light-chain-enhancer of activated B cells; Nrf2, nuclear factor (erythroid-derived 2)-like 2; PGC-1α, peroxisome proliferator-activated receptor gamma coactivator 1-alpha; SIRT1, sirtuin 1; TRX-1; thioredoxin-1; C, control; CW, curcumin, Ex, exercise.